About Cenduit
Cenduit is a Healthcare company based in Durham (United States) founded in 2007. IRT (Interactive Response Technology) specialist offering randomisation and trial supply management services. The company has 563 employees. Its Indian entity Cenduit (India) Services Private Limited reported revenue of ₹74.87 Cr. Its focus areas include HealthTech, Life Sciences Tech, Research & Development and Clinical Trials. Its competitors include 4G Clinical, ClinPhone and LabSavvy; 1 of its 3 listed competitors has raised funding.
Company details
Cenduit was established in 2007 as a joint venture between Quintiles and Thermo Fisher Scientific to address needs in patient randomization and drug supply management within clinical trials. Operations are centered in Durham, United States, with expertise focused on interactive response technology (IRT) systems. Services encompass randomization, drug allocation, trial supply management, accountability traceability, patient engagement, system integration, reporting, and forecasting for pharmaceutical research.
- Headquarters Durham, United States
- Employees 563
- SectorsHealthcare
- Website cenduit.com
- Social LinkedIn X Facebook Instagram
- Legal Name Cenduit (India) Services Private Limited
- Date of Incorporation 20 Mar, 2007
- Jurisdiction Bangalore, Karnataka, India
- Indian entity revenue₹74.87 Cr
FY 2021 · +8% YoY
- Indian entity net profit₹7.35 Cr
FY 2021 · 10% margin
- Indian entity EBITDA₹17.74 Cr
FY 2021 · 24% margin
- Employee Count563
Associated legal entities of Cenduit
Cenduit operates through Cenduit (India) Services Private Limited (amalgamated). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2021) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Cenduit (India) Services Private Limited CIN U72200KA2007PTC042174 | Amalgamated | 20 Mar 2007 | Bangalore, Karnataka | ₹74.9 Cr | 563 | 3 | View details |
Board of directors of Cenduit (India) Services Private Limited (Cenduit)
Cenduit (India) Services Private Limited is the primary company behind Cenduit. The board of Cenduit (India) Services Private Limited currently have 3 directors; the longest-serving is Nilanjan Sinha, appointed in 2017. 15 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Nilanjan Sinha DIN 07653553 | Director | 08 Mar 2017 | 9 yrs 7 mo | Cenduit (India) Services Private Limited |
| Gaurav Shankar Lal DIN 09060003 | Director | 15 Jun 2021 | 5 yrs 4 mo | Cenduit (India) Services Private Limited |
| Arjun Aiyar DIN 07314681 | Director | 15 Jun 2021 | 5 yrs 4 mo | Cenduit (India) Services Private Limited |
People of Cenduit
9 people are tracked at Cenduit (3 in leadership, 6 in team); the tracked headcount is 563.
| Name | Role | Group |
|---|---|---|
Sam Osman | CEO | Leadership |
Pete Smith | Director Of Product Management | Leadership |
Mike Ederle | Senior Vice President Of Finance | Leadership |
Sandesh Y | Senior Product Owner R&d | Team |
Jeremy Star | Product Manager | Team |
Jason Wang | System Design Project Manager III | Team |
Eiichi Nagano | Sr PM | Team |
Christopher S. Smith | Senior Ux/ui Engineer | Team |
Veena K S | Product Owner | Team |
Complete people profiles for Cenduit
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Cenduit
Figures of Cenduit (India) Services Private Limited, the primary company behind Cenduit, for FY 2021. Revenue was ₹74.87 Cr (+8% year on year). Net profit was ₹7.35 Cr (10% margin). EBITDA was ₹17.74 Cr (24% margin). Revenue has grown at a compounded annual rate of +4% over three years and +4% over five years.
- ₹74.87 CrRevenue · FY 2021 · +8% YoY
- ₹7.35 CrNet profit · 10% margin
- ₹17.74 CrEBITDA · 24% margin
- ₹4.55 CrPaid-up capital
- 563Employees (provident fund records)
- +4%Revenue CAGR, 3 years
- +4%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Cenduit (India) Services Private Limited are on its company page.
Detailed financial statements for Cenduit
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of Cenduit
Cenduit has 3 listed competitors in our database, 1 of them funded. They include 4G Clinical, ClinPhone and LabSavvy.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| 4gclinical.com | 2015 | Dover, United States | $259.28M | 201 | Randomization and Trial Supply Management (RTSM) solutions for clinical trials | |
| clinphone.com | 1993 | Princeton, United States | ClinPhone provides technology solutions to the clinical trials industry. | |||
| labsavvy.com | 2004 | Falls Church, United States | Streamlines lab ordering with AI and SaaS for healthcare providers and labs. |
Detailed competitors of Cenduit
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as Cenduit (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Cenduit
Complete news archive for Cenduit
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cenduit
Cenduit was founded in 2007.
Cenduit is headquartered in Durham, United States. It is registered at Durham, North Carolina, United States.
Cenduit has 563 employees.
The primary company behind Cenduit, Cenduit (India) Services Private Limited, reported revenue of ₹74.87 Cr for FY 2021, up 8% year on year.
Cenduit was established in 2007 as a joint venture between Quintiles and Thermo Fisher Scientific to address needs in patient randomization and drug supply management within clinical trials. Operations are centered in Durham, United States, with expertise focused on interactive response technology (IRT) systems. Services encompass randomization, drug allocation, trial supply management, accountability traceability, patient engagement, system integration, reporting, and forecasting for pharmaceutical research.
Cenduit's top competitors include 4G Clinical, ClinPhone and LabSavvy.
Cenduit operates through Cenduit (India) Services Private Limited.
The legal entities of Cenduit currently have 3 directors, including Nilanjan Sinha, Gaurav Shankar Lal, Arjun Aiyar.